| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.06e-07 | 188 | 112 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.86e-04 | 4 | 112 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium ion binding | FBLN7 FBLN5 EFEMP2 VWCE TENM2 RYR2 RYR3 THBD EFEMP1 HMCN2 HMCN1 DLK2 NOTCH2 | 2.92e-04 | 749 | 112 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.55e-04 | 27 | 112 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.61e-04 | 6 | 112 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | transition metal ion binding | UBA5 TRAF6 CAD FN1 LITAF OGFOD2 ZNFX1 UBR7 F8 TAB3 ZPR1 ARIH2 ANKIB1 DMD ZSWIM4 PCK2 | 9.66e-04 | 1189 | 112 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.07e-03 | 36 | 112 | 3 | GO:0031624 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.09e-03 | 9 | 112 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.09e-03 | 9 | 112 | 2 | GO:0001640 | |
| GeneOntologyBiologicalProcess | elastic fiber assembly | 2.36e-05 | 11 | 110 | 3 | GO:0048251 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell-matrix adhesion | 2.82e-05 | 2 | 110 | 2 | GO:1905609 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 FBLN7 FBLN5 FN1 EFEMP2 TFIP11 SSPOP TSPAN9 EFEMP1 HMCN2 HMCN1 ADAMTS6 SBSPON MUC6 CCN3 | 1.79e-06 | 656 | 110 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 FBLN7 FBLN5 FN1 EFEMP2 TFIP11 SSPOP TSPAN9 EFEMP1 HMCN2 HMCN1 ADAMTS6 SBSPON MUC6 CCN3 | 1.86e-06 | 658 | 110 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 FBLN5 FN1 EFEMP2 SSPOP TSPAN9 EFEMP1 HMCN2 HMCN1 SBSPON CCN3 | 1.11e-04 | 530 | 110 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | elastic fiber | 2.72e-04 | 5 | 110 | 2 | GO:0071953 | |
| GeneOntologyCellularComponent | basement membrane | 4.68e-04 | 122 | 110 | 5 | GO:0005604 | |
| MousePheno | abnormal ascending aorta morphology | 1.12e-05 | 22 | 91 | 4 | MP:0009867 | |
| Domain | EGF_1 | FBLN7 FBLN5 FN1 EFEMP2 ADAM29 VWCE SSPOP TENM2 THBD EFEMP1 HMCN2 HMCN1 TENM3 DLK2 NOTCH2 | 2.29e-11 | 255 | 109 | 15 | PS00022 |
| Domain | EGF_3 | FBLN7 FBLN5 EFEMP2 ADAM29 VWCE SSPOP TENM2 THBD EFEMP1 HMCN2 HMCN1 TENM3 DLK2 NOTCH2 | 9.41e-11 | 235 | 109 | 14 | PS50026 |
| Domain | EGF_CA | FBLN7 FBLN5 EFEMP2 VWCE TENM2 THBD EFEMP1 HMCN2 HMCN1 DLK2 NOTCH2 | 1.31e-10 | 122 | 109 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FBLN7 FBLN5 EFEMP2 VWCE TENM2 THBD EFEMP1 HMCN2 HMCN1 DLK2 NOTCH2 | 1.56e-10 | 124 | 109 | 11 | IPR001881 |
| Domain | EGF-like_dom | PCSK5 FBLN7 FBLN5 EFEMP2 ADAM29 VWCE TENM2 THBD EFEMP1 HMCN2 HMCN1 TENM3 DLK2 NOTCH2 | 2.02e-10 | 249 | 109 | 14 | IPR000742 |
| Domain | EGF_Ca-bd_CS | 2.48e-10 | 97 | 109 | 10 | IPR018097 | |
| Domain | EGF_CA | 3.04e-10 | 99 | 109 | 10 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.36e-10 | 100 | 109 | 10 | PS00010 | |
| Domain | EGF-like_CS | FBLN7 FBLN5 FN1 EFEMP2 ADAM29 VWCE TENM2 THBD EFEMP1 HMCN2 HMCN1 TENM3 DLK2 NOTCH2 | 3.76e-10 | 261 | 109 | 14 | IPR013032 |
| Domain | EGF_2 | FBLN7 FBLN5 EFEMP2 ADAM29 VWCE SSPOP TENM2 THBD EFEMP1 HMCN2 HMCN1 TENM3 DLK2 NOTCH2 | 4.59e-10 | 265 | 109 | 14 | PS01186 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.01e-10 | 106 | 109 | 10 | IPR000152 | |
| Domain | EGF_CA | 1.78e-09 | 86 | 109 | 9 | PF07645 | |
| Domain | EGF | PCSK5 FBLN7 FBLN5 EFEMP2 VWCE TENM2 THBD EFEMP1 HMCN1 TENM3 DLK2 NOTCH2 | 1.27e-08 | 235 | 109 | 12 | SM00181 |
| Domain | Growth_fac_rcpt_ | 2.60e-08 | 156 | 109 | 10 | IPR009030 | |
| Domain | cEGF | 3.68e-07 | 26 | 109 | 5 | PF12662 | |
| Domain | cEGF | 3.68e-07 | 26 | 109 | 5 | IPR026823 | |
| Domain | DUF4599 | 5.24e-07 | 12 | 109 | 4 | PF15371 | |
| Domain | DUF4599 | 5.24e-07 | 12 | 109 | 4 | IPR027970 | |
| Domain | TSP_1 | 1.78e-06 | 63 | 109 | 6 | PF00090 | |
| Domain | TSP1 | 2.15e-06 | 65 | 109 | 6 | SM00209 | |
| Domain | TSP1_rpt | 2.15e-06 | 65 | 109 | 6 | IPR000884 | |
| Domain | TSP1 | 2.15e-06 | 65 | 109 | 6 | PS50092 | |
| Domain | PLAC | 6.72e-05 | 14 | 109 | 3 | PF08686 | |
| Domain | Rhs_assc_core | 1.01e-04 | 3 | 109 | 2 | IPR022385 | |
| Domain | Ryanodine_rcpt | 1.01e-04 | 3 | 109 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.01e-04 | 3 | 109 | 2 | IPR009460 | |
| Domain | RyR | 1.01e-04 | 3 | 109 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.01e-04 | 3 | 109 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.01e-04 | 3 | 109 | 2 | IPR013333 | |
| Domain | VWF_dom | 1.04e-04 | 42 | 109 | 4 | IPR001007 | |
| Domain | VWC_out | 1.75e-04 | 19 | 109 | 3 | SM00215 | |
| Domain | PLAC | 1.75e-04 | 19 | 109 | 3 | PS50900 | |
| Domain | PLAC | 1.75e-04 | 19 | 109 | 3 | IPR010909 | |
| Domain | Tox-GHH_dom | 2.01e-04 | 4 | 109 | 2 | IPR028916 | |
| Domain | G2F | 2.01e-04 | 4 | 109 | 2 | PF07474 | |
| Domain | Tox-GHH | 2.01e-04 | 4 | 109 | 2 | PF15636 | |
| Domain | NIDOGEN_G2 | 2.01e-04 | 4 | 109 | 2 | PS50993 | |
| Domain | GFP | 2.01e-04 | 4 | 109 | 2 | IPR009017 | |
| Domain | Ten_N | 2.01e-04 | 4 | 109 | 2 | IPR009471 | |
| Domain | Ten_N | 2.01e-04 | 4 | 109 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.01e-04 | 4 | 109 | 2 | PS51361 | |
| Domain | G2_nidogen/fibulin_G2F | 2.01e-04 | 4 | 109 | 2 | IPR006605 | |
| Domain | Galactose-bd-like | 2.24e-04 | 94 | 109 | 5 | IPR008979 | |
| Domain | zf-RanBP | 2.75e-04 | 22 | 109 | 3 | PF00641 | |
| Domain | ZnF_RBZ | 3.15e-04 | 23 | 109 | 3 | SM00547 | |
| Domain | ZF_RANBP2_2 | 3.15e-04 | 23 | 109 | 3 | PS50199 | |
| Domain | YD | 3.34e-04 | 5 | 109 | 2 | IPR006530 | |
| Domain | ZF_RANBP2_1 | 3.58e-04 | 24 | 109 | 3 | PS01358 | |
| Domain | Znf_RanBP2 | 4.05e-04 | 25 | 109 | 3 | IPR001876 | |
| Domain | Cys_knot_C | 4.05e-04 | 25 | 109 | 3 | IPR006207 | |
| Domain | CTCK_2 | 4.05e-04 | 25 | 109 | 3 | PS01225 | |
| Domain | RIH_assoc-dom | 4.99e-04 | 6 | 109 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 4.99e-04 | 6 | 109 | 2 | PF08709 | |
| Domain | RIH_assoc | 4.99e-04 | 6 | 109 | 2 | PF08454 | |
| Domain | RIH_dom | 4.99e-04 | 6 | 109 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.99e-04 | 6 | 109 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.99e-04 | 6 | 109 | 2 | IPR015925 | |
| Domain | - | 4.99e-04 | 6 | 109 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.99e-04 | 6 | 109 | 2 | PF01365 | |
| Domain | Tetraspanin | 8.48e-04 | 32 | 109 | 3 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 8.48e-04 | 32 | 109 | 3 | IPR008952 | |
| Domain | EGF | 8.61e-04 | 126 | 109 | 5 | PF00008 | |
| Domain | - | 8.77e-04 | 73 | 109 | 4 | 2.60.120.260 | |
| Domain | GPCR_3_mtglu_rcpt | 9.24e-04 | 8 | 109 | 2 | IPR000162 | |
| Domain | Tetraspanin/Peripherin | 9.29e-04 | 33 | 109 | 3 | IPR018499 | |
| Domain | Tetraspannin | 9.29e-04 | 33 | 109 | 3 | PF00335 | |
| Domain | VWFC_1 | 1.20e-03 | 36 | 109 | 3 | PS01208 | |
| Domain | - | 1.26e-03 | 449 | 109 | 9 | 3.30.40.10 | |
| Domain | VWFC_2 | 1.41e-03 | 38 | 109 | 3 | PS50184 | |
| Domain | VWC | 1.41e-03 | 38 | 109 | 3 | SM00214 | |
| Domain | Znf_RING/FYVE/PHD | 1.47e-03 | 459 | 109 | 9 | IPR013083 | |
| Domain | MIR | 1.47e-03 | 10 | 109 | 2 | PF02815 | |
| Domain | - | 1.47e-03 | 10 | 109 | 2 | 4.10.1060.10 | |
| Domain | MIR_motif | 1.47e-03 | 10 | 109 | 2 | IPR016093 | |
| Domain | MIR | 1.47e-03 | 10 | 109 | 2 | PS50919 | |
| Domain | MIR | 1.47e-03 | 10 | 109 | 2 | SM00472 | |
| Domain | E3_UB_ligase_RBR | 1.47e-03 | 10 | 109 | 2 | IPR031127 | |
| Domain | Peripla_BP_I | 1.52e-03 | 39 | 109 | 3 | IPR028082 | |
| Domain | Znf_FYVE_PHD | 1.71e-03 | 147 | 109 | 5 | IPR011011 | |
| Domain | ABC_A | 2.14e-03 | 12 | 109 | 2 | IPR026082 | |
| Domain | C8 | 2.14e-03 | 12 | 109 | 2 | PF08742 | |
| Domain | TIL | 2.14e-03 | 12 | 109 | 2 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.52e-03 | 13 | 109 | 2 | IPR014853 | |
| Domain | NCD3G | 2.52e-03 | 13 | 109 | 2 | PF07562 | |
| Domain | C8 | 2.52e-03 | 13 | 109 | 2 | SM00832 | |
| Domain | GPCR_3_9-Cys_dom | 2.52e-03 | 13 | 109 | 2 | IPR011500 | |
| Domain | NHL | 2.52e-03 | 13 | 109 | 2 | PS51125 | |
| Domain | WW | 2.60e-03 | 47 | 109 | 3 | PF00397 | |
| Domain | WW | 2.76e-03 | 48 | 109 | 3 | SM00456 | |
| Domain | TIL_dom | 2.93e-03 | 14 | 109 | 2 | IPR002919 | |
| Domain | IBR | 2.93e-03 | 14 | 109 | 2 | PF01485 | |
| Domain | IBR | 2.93e-03 | 14 | 109 | 2 | SM00647 | |
| Domain | GPCR_3_CS | 2.93e-03 | 14 | 109 | 2 | IPR017979 | |
| Domain | WW_DOMAIN_1 | 3.29e-03 | 51 | 109 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.29e-03 | 51 | 109 | 3 | PS50020 | |
| Domain | START_lipid-bd_dom | 3.37e-03 | 15 | 109 | 2 | IPR002913 | |
| Domain | START | 3.37e-03 | 15 | 109 | 2 | PF01852 | |
| Domain | IBR_dom | 3.37e-03 | 15 | 109 | 2 | IPR002867 | |
| Domain | START | 3.37e-03 | 15 | 109 | 2 | PS50848 | |
| Domain | WW_dom | 3.47e-03 | 52 | 109 | 3 | IPR001202 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.12e-06 | 68 | 79 | 6 | M27303 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.24e-05 | 37 | 79 | 4 | M27134 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.47e-05 | 39 | 79 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.47e-05 | 39 | 79 | 4 | MM15165 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.05e-04 | 44 | 79 | 4 | M26969 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.48e-04 | 143 | 79 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.61e-04 | 109 | 79 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.92e-04 | 111 | 79 | 5 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.96e-04 | 250 | 79 | 7 | M27554 | |
| Pubmed | 2.07e-12 | 6 | 114 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.07e-12 | 6 | 114 | 5 | 25930072 | |
| Pubmed | Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. | 1.63e-09 | 6 | 114 | 4 | 20595023 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | CALCOCO2 FBLN5 FN1 EFEMP2 TFIP11 VWCE SRRT EFEMP1 CACTIN-AS1 SHARPIN ANKIB1 GRIP2 NOTCH2 CCN3 | 4.80e-09 | 560 | 114 | 14 | 21653829 |
| Pubmed | 1.40e-08 | 24 | 114 | 5 | 32212159 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23782690 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 17324935 | ||
| Pubmed | Crosstalk Between NDP52 and LUBAC in Innate Immune Responses, Cell Death, and Xenophagy. | 2.84e-06 | 9 | 114 | 3 | 33815386 | |
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | CALCOCO2 FBLN5 ISYNA1 GGA2 LITAF EFEMP2 TFIP11 CFHR5 PNPO EFEMP1 DMD | 4.06e-06 | 590 | 114 | 11 | 25910212 |
| Pubmed | 4.79e-06 | 285 | 114 | 8 | 34369648 | ||
| Pubmed | 4.98e-06 | 75 | 114 | 5 | 20637190 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 26555638 | ||
| Pubmed | Differential expression of fibulins in the uterosacral ligaments of women with uterine prolapse. | 1.07e-05 | 2 | 114 | 2 | 19862539 | |
| Pubmed | The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages. | 1.07e-05 | 2 | 114 | 2 | 29306077 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10982184 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8898078 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 14550562 | ||
| Pubmed | TRAF6 regulates proliferation and differentiation of skeletal myoblasts. | 1.07e-05 | 2 | 114 | 2 | 21131124 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19298530 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19229767 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.07e-05 | 2 | 114 | 2 | 21531043 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16678258 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24163132 | ||
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 1.07e-05 | 2 | 114 | 2 | 32035013 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10601734 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 30181262 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 14985349 | ||
| Pubmed | Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. | 1.52e-05 | 15 | 114 | 3 | 23986494 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.59e-05 | 95 | 114 | 5 | 29643511 | |
| Pubmed | 1.95e-05 | 167 | 114 | 6 | 22159717 | ||
| Pubmed | 2.53e-05 | 175 | 114 | 6 | 28071719 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 12388743 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18403125 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 3.19e-05 | 3 | 114 | 2 | 29730765 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 7876312 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23642367 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 3.19e-05 | 3 | 114 | 2 | 10788707 | |
| Pubmed | Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. | 3.19e-05 | 3 | 114 | 2 | 22829427 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 3.19e-05 | 3 | 114 | 2 | 7621815 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25713297 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 27602495 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 3.19e-05 | 3 | 114 | 2 | 10473538 | |
| Pubmed | A secreted protein promotes cleavage furrow maturation during cytokinesis. | 3.19e-05 | 3 | 114 | 2 | 21215633 | |
| Pubmed | Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. | 3.19e-05 | 3 | 114 | 2 | 20615971 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 3.19e-05 | 3 | 114 | 2 | 9204703 | |
| Pubmed | Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation. | 3.19e-05 | 3 | 114 | 2 | 21774968 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21881589 | ||
| Pubmed | A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase. | 3.19e-05 | 3 | 114 | 2 | 33239290 | |
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 3.19e-05 | 3 | 114 | 2 | 12213830 | |
| Pubmed | Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. | 3.19e-05 | 3 | 114 | 2 | 20080623 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 9242641 | ||
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 3.19e-05 | 3 | 114 | 2 | 15024040 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17015624 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25239916 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 18643873 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 11159936 | ||
| Pubmed | A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. | 3.19e-05 | 3 | 114 | 2 | 7722646 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 3.19e-05 | 3 | 114 | 2 | 4600883 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 7635066 | ||
| Pubmed | 4.51e-05 | 118 | 114 | 5 | 21078624 | ||
| Pubmed | 5.05e-05 | 22 | 114 | 3 | 36098982 | ||
| Pubmed | 5.05e-05 | 22 | 114 | 3 | 21979435 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 23931754 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 22328512 | ||
| Pubmed | B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. | 6.36e-05 | 4 | 114 | 2 | 10908663 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 6.36e-05 | 4 | 114 | 2 | 10225957 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 26686553 | ||
| Pubmed | Variant mapping and mutation discovery in inbred mice using next-generation sequencing. | 6.36e-05 | 4 | 114 | 2 | 26552429 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 6.36e-05 | 4 | 114 | 2 | 23413940 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 9607712 | ||
| Pubmed | Isolation and characterization of two novel A20-like proteins. | 6.36e-05 | 4 | 114 | 2 | 11463333 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 23482488 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 18206662 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 36007682 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 9384575 | ||
| Pubmed | TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis. | 6.36e-05 | 4 | 114 | 2 | 26619121 | |
| Pubmed | Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1. | 6.36e-05 | 4 | 114 | 2 | 12902636 | |
| Pubmed | TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner. | 6.36e-05 | 4 | 114 | 2 | 37173967 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 6.36e-05 | 4 | 114 | 2 | 12000766 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 34504132 | ||
| Pubmed | Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. | 6.36e-05 | 4 | 114 | 2 | 19855011 | |
| Pubmed | Complexes of tetraspanins with integrins: more than meets the eye. | 6.60e-05 | 24 | 114 | 3 | 11739647 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 6.60e-05 | 24 | 114 | 3 | 35746896 | |
| Pubmed | 6.90e-05 | 129 | 114 | 5 | 23022380 | ||
| Pubmed | 8.50e-05 | 70 | 114 | 4 | 34255829 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 25193470 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 16118233 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 3243547 | ||
| Pubmed | TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer. | 1.06e-04 | 5 | 114 | 2 | 27009840 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.06e-04 | 5 | 114 | 2 | 19011160 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 17699513 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 22766125 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 33060591 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 18180309 | ||
| Pubmed | WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. | 1.06e-04 | 5 | 114 | 2 | 15064722 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 19521662 | ||
| Interaction | UBE2L3 interactions | UBA5 TRAF6 FN1 UBOX5 USP26 ZPR1 ARIH2 ANKIB1 HECTD1 ZRANB1 PCK2 | 2.92e-08 | 211 | 113 | 11 | int:UBE2L3 |
| Interaction | ZNF358 interactions | 3.40e-06 | 19 | 113 | 4 | int:ZNF358 | |
| Interaction | ZNF627 interactions | 4.24e-06 | 20 | 113 | 4 | int:ZNF627 | |
| Interaction | ATG9A interactions | CALCOCO2 PRUNE2 GGA2 WWOX ZFYVE16 INPP5B KPRP ITFG1 WDR11 AP4B1 ZRANB1 NOTCH2 | 7.64e-06 | 445 | 113 | 12 | int:ATG9A |
| Interaction | SNRPD2 interactions | CAD WWOX FN1 TFIP11 TRRAP ITFG1 SRRT ARIH2 HECTD1 ZRANB1 WDR77 | 2.14e-05 | 414 | 113 | 11 | int:SNRPD2 |
| Interaction | EMILIN1 interactions | 2.50e-05 | 103 | 113 | 6 | int:EMILIN1 | |
| Interaction | OTX1 interactions | 2.71e-05 | 155 | 113 | 7 | int:OTX1 | |
| Interaction | TRIP13 interactions | CALCOCO2 PCSK5 FBLN5 WWOX MAD2L1BP M1AP TNFSF13B SHARPIN PLK3 | 2.95e-05 | 281 | 113 | 9 | int:TRIP13 |
| Interaction | ZNF696 interactions | 3.99e-05 | 68 | 113 | 5 | int:ZNF696 | |
| Interaction | ZSCAN2 interactions | 4.71e-05 | 13 | 113 | 3 | int:ZSCAN2 | |
| Interaction | LCE3D interactions | 5.62e-05 | 73 | 113 | 5 | int:LCE3D | |
| Interaction | EGFL7 interactions | 7.26e-05 | 77 | 113 | 5 | int:EGFL7 | |
| Interaction | ZNF747 interactions | 7.33e-05 | 40 | 113 | 4 | int:ZNF747 | |
| Interaction | SH3PXD2A interactions | 8.46e-05 | 128 | 113 | 6 | int:SH3PXD2A | |
| Cytoband | Xp21.2 | 1.69e-04 | 8 | 114 | 2 | Xp21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.69e-04 | 8 | 114 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 1.63e-03 | 24 | 114 | 2 | 9p13.1 | |
| Cytoband | 2q34 | 2.21e-03 | 28 | 114 | 2 | 2q34 | |
| Cytoband | 1p34 | 2.89e-03 | 32 | 114 | 2 | 1p34 | |
| Cytoband | 2p13.1 | 3.26e-03 | 34 | 114 | 2 | 2p13.1 | |
| Cytoband | 9q31.1 | 4.70e-03 | 41 | 114 | 2 | 9q31.1 | |
| GeneFamily | Fibulins | 9.77e-14 | 8 | 73 | 6 | 556 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.81e-05 | 3 | 73 | 2 | 287 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 7.97e-05 | 21 | 73 | 3 | 89 | |
| GeneFamily | CD molecules|Tetraspanins | 3.16e-04 | 33 | 73 | 3 | 768 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 4.43e-04 | 8 | 73 | 2 | 281 | |
| GeneFamily | ATP binding cassette subfamily A | 1.42e-03 | 14 | 73 | 2 | 805 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.63e-03 | 15 | 73 | 2 | 759 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 FBLN7 FBLN5 FN1 EFEMP2 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 SBSPON VWA5B1 CCN3 | 7.34e-14 | 191 | 110 | 14 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 FBLN7 FBLN5 FN1 EFEMP2 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 SBSPON VWA5B1 CCN3 | 1.05e-13 | 196 | 110 | 14 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 FBLN7 FBLN5 FN1 EFEMP2 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 SBSPON VWA5B1 CCN3 | 8.23e-12 | 270 | 110 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 FBLN7 FBLN5 FN1 EFEMP2 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 SBSPON VWA5B1 CCN3 | 1.05e-11 | 275 | 110 | 14 | M5884 |
| Coexpression | NABA_MATRISOME | THSD4 PCSK5 FBLN7 FBLN5 FN1 EFEMP2 OGFOD2 ADAM29 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 ADAMTS6 SBSPON TNFSF13B MUC6 VWA5B1 CCN3 | 6.87e-09 | 1008 | 110 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | THSD4 PCSK5 FBLN7 FBLN5 FN1 EFEMP2 OGFOD2 ADAM29 VWCE SSPOP IGSF10 EFEMP1 HMCN2 HMCN1 ADAMTS6 SBSPON TNFSF13B MUC6 VWA5B1 CCN3 | 9.24e-09 | 1026 | 110 | 20 | M5889 |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN | 2.22e-05 | 200 | 110 | 7 | M7058 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 2.22e-05 | 200 | 110 | 7 | M5679 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 4.99e-06 | 127 | 112 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 2.00e-05 | 157 | 112 | 7 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | ABCA1 GRM3 TENM2 RYR3 THBD EFEMP1 SBSPON UPK1B ERCC6L2 GRIN3A | 5.96e-05 | 407 | 112 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.40e-05 | 261 | 112 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-08 | 196 | 114 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-08 | 196 | 114 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-07 | 171 | 114 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.86e-07 | 184 | 114 | 7 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-07 | 191 | 114 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.22e-07 | 199 | 114 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 153 | 114 | 6 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 159 | 114 | 6 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.71e-06 | 161 | 114 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.98e-06 | 163 | 114 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 4.74e-06 | 168 | 114 | 6 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 172 | 114 | 6 | 4790323a072cfe76127d704665a42c09601d84be | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-06 | 176 | 114 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-06 | 176 | 114 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.26e-06 | 181 | 114 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.26e-06 | 181 | 114 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.48e-06 | 186 | 114 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 186 | 114 | 6 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.48e-06 | 186 | 114 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.01e-06 | 188 | 114 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 9.01e-06 | 188 | 114 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.01e-06 | 188 | 114 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.01e-06 | 188 | 114 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 188 | 114 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 189 | 114 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.29e-06 | 189 | 114 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 189 | 114 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.57e-06 | 190 | 114 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.57e-06 | 190 | 114 | 6 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-06 | 191 | 114 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 9.86e-06 | 191 | 114 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-06 | 191 | 114 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.86e-06 | 191 | 114 | 6 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 192 | 114 | 6 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 192 | 114 | 6 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 193 | 114 | 6 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 194 | 114 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.11e-05 | 195 | 114 | 6 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.11e-05 | 195 | 114 | 6 | 75db19c0371320ea5fce1d6de8c1b40b1e6a2e58 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 195 | 114 | 6 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.14e-05 | 196 | 114 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 196 | 114 | 6 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 196 | 114 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 196 | 114 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 197 | 114 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 197 | 114 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 197 | 114 | 6 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 198 | 114 | 6 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 199 | 114 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-05 | 200 | 114 | 6 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 200 | 114 | 6 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 200 | 114 | 6 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.28e-05 | 200 | 114 | 6 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-05 | 125 | 114 | 5 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.14e-05 | 141 | 114 | 5 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-05 | 146 | 114 | 5 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-05 | 154 | 114 | 5 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 160 | 114 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 160 | 114 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.87e-05 | 82 | 114 | 4 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 161 | 114 | 5 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 161 | 114 | 5 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.27e-05 | 163 | 114 | 5 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.03e-05 | 167 | 114 | 5 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.23e-05 | 168 | 114 | 5 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 170 | 114 | 5 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 170 | 114 | 5 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-05 | 170 | 114 | 5 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-05 | 170 | 114 | 5 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.74e-05 | 88 | 114 | 4 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 171 | 114 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 171 | 114 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-05 | 172 | 114 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-05 | 172 | 114 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 8.30e-05 | 173 | 114 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-05 | 174 | 114 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.76e-05 | 175 | 114 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.76e-05 | 175 | 114 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-05 | 176 | 114 | 5 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 176 | 114 | 5 | fcf324e6402819683f95e0dd94bf1f777c7f4c76 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-05 | 176 | 114 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| Disease | pantothenate measurement | 2.49e-06 | 8 | 106 | 3 | EFO_0021034 | |
| Disease | Cutis Laxa, Autosomal Recessive, Type I | 1.28e-05 | 2 | 106 | 2 | C0268351 | |
| Disease | Cutis laxa, recessive, type I | 1.28e-05 | 2 | 106 | 2 | C0432336 | |
| Disease | amino acid measurement | WWOX ZFYVE16 ABCA12 LITAF TSPAN9 RYR2 RYR3 M1AP GRIP2 CAMTA1 AP4B1 | 3.35e-05 | 678 | 106 | 11 | EFO_0005134 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | cutis laxa (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | Cutis laxa, autosomal recessive | 1.27e-04 | 5 | 106 | 2 | cv:C3665335 | |
| Disease | periodontitis | 1.58e-04 | 223 | 106 | 6 | EFO_0000649 | |
| Disease | Cutis Laxa | 1.90e-04 | 6 | 106 | 2 | C0010495 | |
| Disease | Glaucoma | 1.90e-04 | 6 | 106 | 2 | cv:C0017601 | |
| Disease | Colorectal Carcinoma | 2.23e-04 | 702 | 106 | 10 | C0009402 | |
| Disease | triacylglycerol 58:6 measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0010440 | |
| Disease | urate measurement, bone density | 4.01e-04 | 619 | 106 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | upper face morphology measurement | 4.22e-04 | 97 | 106 | 4 | EFO_0010949 | |
| Disease | Thrombophilia | 4.53e-04 | 9 | 106 | 2 | C0398623 | |
| Disease | temporomandibular joint disorder | 5.65e-04 | 10 | 106 | 2 | EFO_0005279 | |
| Disease | unipolar depression, sex interaction measurement | 8.28e-04 | 51 | 106 | 3 | EFO_0003761, EFO_0008343 | |
| Disease | response to efavirenz, virologic response measurement | 1.20e-03 | 58 | 106 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | Tinnitus | 1.26e-03 | 130 | 106 | 4 | HP_0000360 | |
| Disease | glycerate measurement | 1.30e-03 | 15 | 106 | 2 | EFO_0021029 | |
| Disease | diverticular disease | 1.65e-03 | 236 | 106 | 5 | EFO_0009959 | |
| Disease | common carotid intimal medial thickness | 1.83e-03 | 67 | 106 | 3 | EFO_0004860 | |
| Disease | Age-related macular degeneration | 1.88e-03 | 18 | 106 | 2 | cv:C0242383 | |
| Disease | susceptibility to mononucleosis measurement | 1.99e-03 | 69 | 106 | 3 | EFO_0008403 | |
| Disease | lung cancer | 2.57e-03 | 21 | 106 | 2 | MONDO_0008903 | |
| Disease | Lung diseases | 2.82e-03 | 78 | 106 | 3 | C0024115 | |
| Disease | Glioblastoma | 2.92e-03 | 79 | 106 | 3 | C0017636 | |
| Disease | Colorectal Neoplasms | 3.30e-03 | 277 | 106 | 5 | C0009404 | |
| Disease | unipolar depression, neuroticism measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | Giant Cell Glioblastoma | 3.48e-03 | 84 | 106 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QCDGMRICEQAPQQA | 741 | Q9BXU7 | |
| CGRIQCENVTEIPNM | 551 | Q9UKF5 | |
| QAEMCLPCCSPQQGS | 816 | Q9Y6Y1 | |
| PGIDNMCLNTSDLQC | 1811 | Q86UK0 | |
| TSQCSDPCAPNEMKN | 506 | Q14832 | |
| NQVNLASCCVMPPDL | 186 | P48507 | |
| MQNPSPACQCSSDKI | 1456 | O95477 | |
| AINTLCKDCSDPNPM | 86 | Q9Y6B7 | |
| NPENCCQRSGVQMPT | 276 | Q9P2G1 | |
| VSCMAQDCPLRTPED | 181 | O95376 | |
| NNLVNVPLCVDMCLN | 3166 | P11532 | |
| ASKPRMNEGTPQCAC | 196 | Q8N1I8 | |
| CLETVRPPSMQQCES | 1056 | Q9UKP5 | |
| MELSCPGSRCPVQEQ | 1 | Q8N4T4 | |
| MAPNCLRCQSDDPRV | 1041 | Q9C0H5 | |
| LCQRVSFCTDMDPEP | 436 | Q9NPH2 | |
| TFLDRPIQMCCPSCN | 86 | Q99732 | |
| FQCERNPCPMDSRPC | 316 | Q53RD9 | |
| NCPAALERETDPCSM | 566 | Q6W4X9 | |
| CETFVDVCPQMPCLN | 1301 | Q04721 | |
| AVRNSLCPMCCREPD | 311 | Q6N063 | |
| EPLNASEAFCPRDCM | 41 | Q15013 | |
| RPRDNPMCLKCDLQE | 251 | Q8TC57 | |
| RMQGPSLPCLDVNEC | 4746 | Q8NDA2 | |
| QELSNEENCCAPIPM | 1136 | Q9Y3R5 | |
| NNFDPACCPAKMILD | 541 | Q5HYC2 | |
| SQPVLMDINAVLCCP | 41 | Q6Q8B3 | |
| PAEDQCQTCPMNSLL | 1481 | Q92824 | |
| NSRFCAPARQCPIMD | 421 | Q16822 | |
| ECDTRQSLQQSMPPC | 1436 | Q9UHC1 | |
| CPACQNMLFESIQEG | 311 | Q9HBH9 | |
| MVSGQNCCEEKRNPS | 386 | Q9UJY4 | |
| TENMERNCRAPCNIQ | 1911 | P00451 | |
| RNCRAPCNIQMEDPT | 1916 | P00451 | |
| QCPDIGEANAMCLAT | 71 | Q9NVS9 | |
| LSCELCPLDQRPNMN | 551 | O00222 | |
| CPLDQRPNMNRTGCQ | 556 | O00222 | |
| CQDMKEPEDNSPNTC | 191 | Q9BXL5 | |
| KPCQGSDLEMRNCQN | 4566 | Q96RW7 | |
| SDLEMRNCQNKPCPV | 4571 | Q96RW7 | |
| SQIQRCNTDMCPVDG | 4801 | Q96RW7 | |
| LCPAGQLCLDPMTND | 536 | Q8TCU5 | |
| LMSDNVDRCFETCPP | 36 | Q9ULT8 | |
| DRSPSSAQQCPLCMN | 246 | Q6WRI0 | |
| SAQQCPLCMNPRTSK | 251 | Q6WRI0 | |
| PDPDLLTCGQCQMNF | 51 | Q9C0K0 | |
| TRLCMVRPCEQEPEQ | 241 | P48745 | |
| RACCFQAVPPSNMKQ | 96 | A8K010 | |
| RTNTNVNCPIECFMP | 2451 | P02751 | |
| VNCPIECFMPLDVQA | 2456 | P02751 | |
| RQDCAEMTAPSPSCA | 591 | Q5T1N1 | |
| EQQQMQPLCFNCPIC | 411 | Q13137 | |
| PRCLDPCVVSEENMN | 501 | Q9BXR6 | |
| KDICSRMQFCQPDPS | 496 | P32019 | |
| VVQAPCEMQIVDCPA | 36 | Q5T749 | |
| NRMALCVSNCPEEQL | 111 | Q8N4M1 | |
| CEVNVDDCLMRPCAN | 171 | Q6UY11 | |
| PACQDQECQVSMLPA | 351 | Q6UY11 | |
| LEMPRQPDCQECRGT | 736 | Q5T890 | |
| RISDNRCMCPAENPG | 326 | Q9UBX5 | |
| NCPMEDAVQILRQCE | 616 | Q9C0E4 | |
| PNNRSCVDVNECDMG | 196 | O95967 | |
| FNMPRLVQCANVAPC | 156 | O75712 | |
| NASLPNDTQRAMEPC | 81 | Q8TCC7 | |
| TCPDMCPAAERAQRE | 56 | A6NKF1 | |
| NNPERAEMCCTALNS | 3256 | Q92736 | |
| PNAPACMERQLEAAR | 21 | Q9BQA1 | |
| LTPENRCVCPVSNAM | 371 | Q12805 | |
| VCCRLAAQPLCMTQP | 296 | Q9BST9 | |
| DLSQMNCPACQGPLT | 286 | Q7L3T8 | |
| PMTCTACQRPVASQD | 521 | O94941 | |
| QPGQCCTDNPVMLDA | 211 | Q9Y3M8 | |
| MFCNQTACPADCDPN | 406 | P07204 | |
| QAPDPCLMARETQNQ | 586 | Q8IWB6 | |
| CLMARETQNQDAPCP | 591 | Q8IWB6 | |
| QEQCQDTMLPVCDHP | 1956 | Q8WUY3 | |
| QPCTAQCPENMLFRS | 2881 | A2VEC9 | |
| NCTMGDPLQERPCNL | 3916 | A2VEC9 | |
| NHPALNRCEQCEMPR | 696 | Q8N5C8 | |
| VPQCRVPLETCMLAN | 951 | Q5VVP1 | |
| PQCRVPLETCMLANL | 956 | Q8IWB4 | |
| RALSCPSQTMQCQLP | 226 | Q8NDZ2 | |
| NAPDRPGCEMCSTQR | 361 | Q9H0F6 | |
| AECDVPMNQCIDPSC | 631 | Q9NT68 | |
| MGTNEAACLLDNPLC | 251 | O94844 | |
| CPQERNPSECKSQEM | 2011 | Q9P2P6 | |
| NPSECKSQEMLNPNR | 2016 | Q9P2P6 | |
| CPDDCPAQMQTRTQA | 166 | Q9BRJ9 | |
| QCCQESEVLERQMCP | 456 | Q9H930 | |
| NTCEYPNEDEMPNRC | 626 | Q9BXP5 | |
| PQCRVPLETCMLANL | 956 | Q5VYP0 | |
| CALRNCIAFMPPAEQ | 436 | Q9H4B4 | |
| STNCPECNAPAQTNM | 256 | O75312 | |
| VCVDCQPPAMNSVSL | 201 | Q8IVN8 | |
| PQCRVPLETCMLANL | 956 | Q5TZJ5 | |
| QPPDNMETLCAPQVC | 661 | O15027 | |
| PQCRVPLETCMLANL | 956 | Q5VU36 | |
| MLLNFQLGENCPCPE | 1876 | Q15413 | |
| SMKPNPQCDDRNCRK | 296 | Q9GZZ9 | |
| RNCPICRLQMTGANE | 186 | Q8WVD5 | |
| EFALMDCPQCQRPFQ | 156 | Q9Y4K3 | |
| CQNGEVECSFMPCPE | 526 | Q96DN2 | |
| FNNCCRCMPSPEAQS | 376 | Q9NZC7 | |
| MDPDCCLQSSCQNQP | 796 | Q9P273 | |
| NPCGLESECLNRMLQ | 1106 | Q9BZ95 | |
| NCVTVCNMENLDPLG | 611 | P27708 | |
| DRLMLQDNCCGVNGP | 151 | O75841 | |
| RENNQIGPMLRLCCQ | 1251 | Q9P2E3 | |
| PPESGDFQEMVCQAC | 171 | Q8N806 | |
| NVPCNNASCEEARRM | 366 | Q8TB96 | |
| RPNDIENCDMGPCAK | 781 | Q6ZMP0 | |
| VRPFSMVCCPVNENA | 356 | Q9BZH6 | |
| PPDFLQLTFNCCNMD | 281 | Q96S53 | |
| QLTFNCCNMDPKLRP | 286 | Q96S53 | |
| RCIQNMPETLPNNSC | 231 | Q9Y275 | |
| PPSCCMNETDCNPQD | 171 | P41732 | |
| ALNCFVEAMSQCVPP | 2671 | Q9Y4A5 | |
| EECERRMQPDCSNPL | 381 | Q9UBB9 | |
| RMQPDCSNPLTLDEC | 386 | Q9UBB9 | |
| SQQAAKCIPAMVCPE | 336 | Q9UGI0 | |
| GENTVPDRCCMENSQ | 161 | O75954 | |
| PDSEAPNCMNCQVKF | 746 | Q7Z3T8 | |
| MLNFCPDLQSVQPCL | 341 | Q5TIE3 | |
| QPTDNPTMDLLRVNC | 636 | B1ANS9 | |
| NSVPQDICCMAADGR | 121 | Q8NI36 | |
| QCAMKDPQNCALPAL | 761 | Q9H7M6 | |
| CLGACVNAPMVQIND | 176 | P19404 |